跳至主要内容
临床试验/NL-OMON40484
NL-OMON40484撤回不适用

Response to influenza and pneumococcal vaccination in myeloma patients treated with Lenalidomide with/without steroiden. - REVIVA

Sint Antonius Ziekenhuis0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patients with multiple myeloma who are treated with lenalidomide with/without steroids.
  • 2. Age > 18 years
  • 3. Signing informed consent.;Control group:
  • 1. Age, sex and co-morbity matched
  • 2. Age >18 years
  • 3. Signing informed consent

排除标准

  • 1. Fever at time of vaccination
  • 2. Completion of Lenalidomide therapy prior to vaccination
  • 3. previous/known allergic reaction to any of the components of the influenzavaccin given;Control group:
  • 1. Use of immune supressive drugs
  • 2. Fever at time of vaccination
  • 3. Previous/known allergic reaction to any of the components of the influenzavaccin given

研究者

相似试验

招募中
不适用
Response to influenza virus vaccination in patients immunocompromised due to chemotherapybreast cancer.Mamma carcinoma1004743810006291
NL-OMON33424Sint Antonius Ziekenhuis385
已完成
4 期
The antibody response to pneumococcal vaccination in patients with inflammatory bowel disease patients treated with immunosuppressive agentsantibody responseprotection after vaccination1001796910027665
NL-OMON45696Academisch Medisch Centrum178
进行中(未招募)
1 期
Immune response test as new predictor for successful TKI stop in patients with chronic myeloid leukemiaChronic myeloid leukemiaMedDRA version: 21.0Level: LLTClassification code 10009016Term: Chronic myeloid leukemia in remissionSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10009015Term: Chronic myeloid leukemiaSystem Organ Class: 100000004864MedDRA version: 21.0Level: LLTClassification code 10054352Term: Chronic phase chronic myeloid leukemiaSystem Organ Class: 100000004864
EUCTR2020-002850-26-NLAlbert Schweitzer Hospital57
招募中
不适用
Vaccination response to pneumococcal antigen as novel predictor for successful tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia.
NL-OMON55091Albert Schweitzer Ziekenhuis57
进行中(未招募)
1 期
Immune responses to influenza and pneumococcal conjugate vaccines in older adults compared to middle-aged adults and adults.Healthy volunteers above 25 years of age
EUCTR2019-000836-24-NLational Institute of Health and the Environment385